Disparities in Clinical Trial Participation in Children and Adolescent Patients With a Hematologic Malignancy
Despite a high institutional clinical trial enrollment rate for eligible patients, we found racial and disease-type disparities. Further work is needed to more granularly determine reasons for not offering trial participation or for not enrolling. By better-defining barriers to clinical trial enrollment, targeted institution-level interventions can be created to improve trial enrollment and reduce outcome disparities.
Authors
- Traci Leong (ORCID: https://orcid.org/0000-0003-2347-4260)
- Joshua P. Muñiz (ORCID: https://orcid.org/0000-0001-6050-8912)
- Sharon M. Castellino (ORCID: https://orcid.org/0000-0001-8367-2002)
- Caitlin Monroe (ORCID: https://orcid.org/0000-0002-8596-8162)
- Rebecca Williamson Lewis (ORCID: https://orcid.org/0000-0003-1722-0547)
Institutions
- Emory University (US)
- Aflac (United States) (US)
- Children's Healthcare of Atlanta (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1002/pbc.31641
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00